SYRE Operating Income - Spyre Therapeutics, Inc.

Complete source-backed operating income history.

Available history: 2014-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Operating Income

Date	Operating Income
2026-06-30	-$41.64M
2026-03-31	-$45.64M
2025-12-31	-$57.17M
2025-09-30	-$56.89M
2025-06-30	-$41.94M
2025-03-31	-$53.57M
2024-12-31	-$61.25M
2024-09-30	-$55.39M
2024-06-30	-$44.15M
2024-03-31	-$47.77M
2023-12-31	-$45.91M
2023-09-30	-$18.34M
2023-06-30	-$159.25M
2023-03-31	-$18.81M
2022-12-31	-$19.16M
2022-09-30	-$18.76M
2022-06-30	-$22.42M
2022-03-31	-$24.44M
2021-12-31	-$20.44M
2021-09-30	-$20.29M
2021-06-30	-$6.71M
2021-03-31	-$18.21M
2020-12-31	-$22.78M
2020-09-30	-$18.12M
2020-06-30	-$21.56M
2020-03-31	-$19.02M
2019-12-31	-$21.91M
2019-09-30	-$22.15M
2019-06-30	-$18.62M
2019-03-31	-$17.66M
2018-12-31	-$15.31M
2018-09-30	-$12.24M
2018-06-30	-$9.67M
2018-03-31	-$8.25M
2017-12-31	-$6.63M
2017-09-30	-$8M
2017-06-30	-$6.72M
2017-03-31	-$6.33M
2016-12-31	-$5.54M
2016-09-30	-$6.3M
2016-06-30	-$5.5M
2016-03-31	-$4.57M
2015-12-31	-$4M
2015-09-30	-$3.42M
2015-06-30	-$1.43M
2015-03-31	-$2.47M

Annual Operating Income

Date	Operating Income
2025-12-31	-$209.56M
2024-12-31	-$208.57M
2023-12-31	-$242.3M
2022-12-31	-$84.78M
2021-12-31	-$65.65M
2020-12-31	-$81.48M
2019-12-31	-$80.33M
2018-12-31	-$45.46M
2017-12-31	-$27.68M
2016-12-31	-$21.91M
2015-12-31	-$11.32M
2014-12-31	-$8.9M